IDEXX Laboratories (IDXX) is a publicly traded Healthcare sector company. As of July 5, 2026, IDXX trades at $557.80 with a market cap of $44.00B and a P/E ratio of 40.74. IDXX moved +4.06% today. Year to date, IDXX is -18.25%; over the trailing twelve months it is +2.78%. Its 52-week range spans $356.14 to $769.98. Analyst consensus is buy with an average price target of $703.67. Rallies surfaces IDXX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
7 analysts cover IDXX: 0 strong buy, 4 buy, 3 hold, 0 sell, and 0 strong sell. The consensus rating is buy. The average price target is $703.67.
| Metric | Value |
|---|---|
| Price | $557.80 |
| Market Cap | $44.00B |
| P/E Ratio | 40.74 |
| EPS | $13.69 |
| Dividend Yield | 0.00% |
| 52-Week High | $769.98 |
| 52-Week Low | $356.14 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $4.45B |
| Net Income | $1.10B |
| Gross Margin | 62.05% |
7 analysts cover IDXX: 0 strong buy, 4 buy, 3 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $703.67.